Susquehanna International Group’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7154 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7000 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6856 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6514 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6297 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6123 |
|
|
2020
Q4 | – | Sell |
-56,458
| Closed | -$129K | – | 5595 |
|
|
2020
Q3 | $129K | Sell |
56,458
-4,324
| -7% | -$9.88K | ﹤0.01% | 4041 |
|
|
2020
Q2 | $140K | Sell |
60,782
-3,526
| -5% | -$8.12K | ﹤0.01% | 3833 |
|
|
2020
Q1 | $111K | Buy |
+64,308
| New | +$111K | ﹤0.01% | 4020 |
|
|
2019
Q4 | – | Sell |
-42,354
| Closed | -$123K | – | 5295 |
|
|
2019
Q3 | $123K | Buy |
42,354
+24,932
| +143% | +$72.4K | ﹤0.01% | 4025 |
|
|
2019
Q2 | $68K | Buy |
17,422
+15,347
| +740% | +$59.9K | ﹤0.01% | 4226 |
|
|
2019
Q1 | $10K | Buy |
+2,075
| New | +$10K | ﹤0.01% | 2886 |
|
|
2018
Q2 | – | Sell |
-5,602
| Closed | -$47K | – | 5257 |
|
|
2018
Q1 | $47K | Buy |
5,602
+2,905
| +108% | +$24.4K | ﹤0.01% | 3129 |
|
|
2017
Q4 | $25K | Sell |
2,697
-2,833
| -51% | -$26.3K | ﹤0.01% | 3517 |
|
|
2017
Q3 | $65K | Buy |
+5,530
| New | +$65K | ﹤0.01% | 2943 |
|
|
2017
Q2 | – | Sell |
-5,557
| Closed | -$271K | – | 4803 |
|
|
2017
Q1 | $271K | Buy |
5,557
+3,149
| +131% | +$154K | ﹤0.01% | 2663 |
|
|
2016
Q4 | $79K | Buy |
+2,408
| New | +$79K | ﹤0.01% | 3928 |
|
|
2016
Q3 | – | Sell |
-6,503
| Closed | -$213K | – | 4404 |
|
|
2016
Q2 | $213K | Buy |
+6,503
| New | +$213K | ﹤0.01% | 2713 |
|